(RTTNews) - Biopharmaceutical company Ligand Pharmaceuticals, Inc. (LGND), while reporting a loss in its fourth quarter, compared to prior year's profit, on Thursday confirmed fiscal 2025 forecast.

This set focuses on boosting Aero DMG while providing a team-wide buff when Aero Erosion is applied to an enemy. The 2-piece bonus will potentially provide a respectable 10% increase in Aero DMG ...

Department of Biology, Chemistry and Pharmacy, Institute of Pharmacy, Molecular Design Group, Königin-Luisestr. 2 + 4, 14195 Berlin, Germany Department of Biology, Chemistry and Pharmacy, Institute of ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...